Oral use of interferon-α delays the onset of insulin-dependent diabetes mellitus in nonobese diabetes mice

Journal of Interferon and Cytokine Research

Volumn 19, Issue 8, 1999, Pages 877-879

  Tanaka Kataoka, Mari ^a   Kunikata, Toshio ^a   Takayama, Satoru ^a   Iwaki, Kanso ^a   Fujii, Mitsukiyo ^a   Ohashi, Kunihiro ^a   Ikeda, Masao ^a   Kurimoto, Masashi ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON;

ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; AGE OF ONSET; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; INTERFERON-ALPHA; MICE; MICE, INBRED NOD; OBESITY; WEIGHT LOSS;

ANIMALIA; MURINAE;

EID: 0032858711     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313398     Document Type: Article

References (13)

1. BROD, S.A., KERMAN, R.H., NELSON, L.D., MARSHALL, G.D., JR., HENNINGER, E.M., KHAN, M., JIN, R., and WOLINSKY, J.S. (1997). Ingested IFN-α has biological effects in humans with relapsing-remitting multiple sclerosis. Multiple Sclerosis 3, 1-7.
2. BEILHARZ, M., McDONALD, W., WATSON, M.W., HENG, J., McGEACHIE, J., and LAWSON, CM. (1997). Low-dose type I interferons reduce early virus replication of murine cytomegalovirus in vivo. J. Interferon Cytokine Res. 17, 625-630.
3. FLEISCHMANN, W.R., JR., MASOOR, J., WU, Y.W., and FLEISCHMANN, C.M. (1998). Orally administered IFN-α acts alone and in synergistic combination with intraperitoneally administered IFN-γ to exert an antitumor effect against B16 melanoma in mice, J. Interferon Cytokine Res. 18, 17-20.
4. BROD, S.A., and KHAN, M. (1996). Oral administration of IFNα is superior to subcutaneous administration of IFN-α in the suppression of chronic relapsing experimental and autoimmune encephalomyelitis. J. Autoimmun. 9, 11-20.
5. FLEISCHMANN, R.W., JR., FIELDS, E.E., WANG, J.L., HUGHES, T.K., and STANTON, G.J. (1991). Modulation of peripheral leukocyte counts in mice by oral administration of interferons. Proc. Soc. Exp. Biol. Med. 197, 424-430.
6. NELSON, P.A., AKSELBAND, Y., DEARBORN, S.M., ALSABBAGH, A., JANE TIAN, Z., GONNELLA, P.A., ZAMVIL, S.S., CHEN, Y., and WEINER, H.L, (1996). Effect of oral beta interferon on subsequent immune responsiveness. In: The Oral Tolerance. H.L. Weiner and L.F. Mayer (eds.) Ann. New York Acad. Sci. 778, 145-155.
7. CAMPBELL, I.L., KAY, T.W., OXBROW, L., and HARRISON, L.C. (1991). Essential role for interferon-gamma and interleukin6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87, 739-742.
8. DEBRAY-SACHS, M., CARNAUD, C., BOITARD, C., COHEN, H., GRESSER, I., BEDOSSA, P., and BACH, J.F. (1991). Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J. Autoimmun. 4, 237-248.
9. HULTGREN, B., HUANG, X., DYBDAL, N., and STEWART, T.A. (1996). Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45, 812-817.
10. TOMINAGA, Y., NAGATA, M., YASUDA, H., OKAMOTO, N., ARISAWA, K., MORIYAMA, H., MIKI, M., YOKONO, K., and KASUGA, M. (1998). Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. Clin. Immunol. Immunopathol. 86, 209-218.
11. RAPOPORT, M.J., JARAMILLO, A., ZIPRIS, D., LAZARUS, A.H., SERREZE, D.V., LEITER, E.H., CYOPICK, P., DANSKA, J.S., and DELOVITCH, T.L. (1993). Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178, 87-89.
12. PENNLINE, K.J., ROQUE-GAFFNEY, E., and MONAHAN, M. (1994). Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71, 169-175.
13. BROD, S.A., FOOTE, B., DARCAN, S., PAPOLLA, M., and NELSON, L. (1997). Oral IFN-α delays IDDM in NOD mice. J. Interferon Cytokine Res. 17, S87.